Enteral Autonomy and Days Off Parenteral Support With Teduglutide Treatment for Short Bowel Syndrome in the STEPS Trials.

JPEN J Parenter Enteral Nutr · 2020 · PMC7318286 · PMID 31423614

Europe PMC DOI

hedged sentences

—

closest p

—

boldest claim

The sentences

showed a trendno p-value reported

Patients with ≥ 50% colon‐in‐continuity showed a trend for achieving greater numbers of days per week off PS.

also in 53,322 other papers

a possible trendno p-value reported

When patients were stratified by disease etiology, patients with a vascular or other acute cause of SBS‐IF showed a possible trend for increased numbers of days off PS at the end of STEPS and STEPS‐2 compared with patients with IBD as a cause of SBS‐IF.

also in 1,410 other papers

Quoted from the open-access full text in Europe PMC under the licence the publisher applied. The sentence is reproduced exactly as published; the emphasis is ours.